Lewis H. Titterton Jr., Director at Anixa Biosciences Inc (ANIX), bought 36,488 shares at $4.76 ($174K) on 2021-10-29, disclosed to the SEC on 2021-11-01.
Open-market purchase of $174k ANIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.76 | 18,244 | $87K | 50.0% |
| 2 | $4.76 | 18,244 | $87K | 50.0% |
| Total | $4.76 avg | 36,488 | $174K | 100% |
| Filing → |
| ANIX | BUY | 2026-07-20 | $42K | — | Filing → |
| ANIX | BUY | 2026-07-16 | $9K | — | Filing → |
| ANIX | BUY | 2026-06-17 | $7K | — | Filing → |